Terms: = Colorectal cancer AND SMAD2, MADH2, 4087, ENSG00000175387, MGC34440, MGC22139, hMAD-2, MADR2, JV18-1, hSMAD2, JV18
220 results:
1. Investigating the impact of smad2 and SMAD4 downregulation in colorectal cancer and their correlation with immune markers, prognosis, and drug resistance and sensitivity.
Amani MS; Peymani M
Mol Biol Rep; 2024 Jul; 51(1):831. PubMed ID: 39037563
[TBL] [Abstract] [Full Text] [Related]
2. Introduction of miR-3613-3p as a regulator of transforming growth factor-β (TGF-β) signaling pathway in colorectal cancer.
Jafarian M; Hasannia T; Badameh P; Behmanesh M; Soltani BM
Mol Biol Rep; 2024 Jun; 51(1):728. PubMed ID: 38861185
[TBL] [Abstract] [Full Text] [Related]
3. ARHGAP4 promotes colon cancer metastasis through the TGF-β signaling pathway and may be associated with T cell exhaustion.
Jiang S; Tang Y; Wang X; Guo H; Chen L; Hu G; Cui Y; Liang S; Zuo J; Luo Z; Chen X; Wang X
Biochem Biophys Res Commun; 2024 Aug; 722():150172. PubMed ID: 38805788
[TBL] [Abstract] [Full Text] [Related]
4. OLFM2 promotes epithelial-mesenchymal transition, migration, and invasion in colorectal cancer through the TGF-β/Smad signaling pathway.
Tang Y; Liu Y; Wang X; Guo H; Chen L; Hu G; Cui Y; Liang S; Zuo J; Luo Z; Chen X; Wang X
BMC Cancer; 2024 Feb; 24(1):204. PubMed ID: 38350902
[TBL] [Abstract] [Full Text] [Related]
5. Involucrasin B Inhibits the Proliferation of Caco-2 Cells by Regulating the TGFβ/smad2-3-4 Pathway.
Wang Z; Lin W; Shi M; Hou Y; Liu J; Huang Z; Zhang X; Yang Y; Liu B; Yang Z; Ma W
Molecules; 2024 Feb; 29(3):. PubMed ID: 38338430
[TBL] [Abstract] [Full Text] [Related]
6. TIF1γ and SMAD4 regulation in colorectal cancer: impact on cell proliferation and liver metastasis.
Wu Y; Yu B; Ai X; Zhang W; Chen W; Laurence A; Zhang M; Chen Q; Shao Y; Zhang B
Biol Chem; 2024 Apr; 405(4):241-256. PubMed ID: 38270141
[TBL] [Abstract] [Full Text] [Related]
7. Linderapyrone analogue LPD-01 as a cancer treatment agent by targeting importin7.
Kitagawa T; Matsumoto T; Ohta T; Yoshida T; Saito Y; Nakayama Y; Hadate Y; Ashihara E; Watanabe T
J Nat Med; 2024 Mar; 78(2):370-381. PubMed ID: 38265612
[TBL] [Abstract] [Full Text] [Related]
8. Dynamic regulation of EXO1 promotes the progression from liver fibrosis to HCC through TGF-β1/Smad signaling feedback loop.
Li M; Huang F; Zhu W; Peng Y; Xu F; Li W; Zhao Q; Liu L
Hepatol Commun; 2024 Jan; 8(1):. PubMed ID: 38126949
[TBL] [Abstract] [Full Text] [Related]
9. The role of thrombomodulin in modulating ITGB3 expression and its implications for triple-negative breast cancer progression.
Chang YJ; Prince GMSH; Wei PL; Batzorig U; Huang CY; Hung CS; Chang TC
Cell Biol Int; 2024 Feb; 48(2):216-228. PubMed ID: 38081783
[TBL] [Abstract] [Full Text] [Related]
10. Exosomal circCOL1A1 promotes angiogenesis via recruiting EIF4A3 protein and activating smad2/3 pathway in colorectal cancer.
Hu G; Lin C; Gao K; Chen M; Long F; Tian B
Mol Med; 2023 Nov; 29(1):155. PubMed ID: 37940881
[TBL] [Abstract] [Full Text] [Related]
11. The apelin‑apelin receptor signaling pathway in fibroblasts is involved in tumor growth via p53 expression of cancer cells.
Saiki H; Hayashi Y; Yoshii S; Kimura E; Nakagawa K; Kato M; Uema R; Inoue T; Sakatani A; Yoshihara T; Tsujii Y; Shinzaki S; Iijima H; Takehara T
Int J Oncol; 2023 Dec; 63(6):. PubMed ID: 37921070
[TBL] [Abstract] [Full Text] [Related]
12. A potential tumor marker: Chaperonin containing TCP‑1 controls the development of malignant tumors (Review).
Zheng L; Chen X; Zhang L; Qin N; An J; Zhu J; Jin H; Tuo B
Int J Oncol; 2023 Sep; 63(3):. PubMed ID: 37539774
[TBL] [Abstract] [Full Text] [Related]
13. A Short-Term Model of Colitis-Associated colorectal cancer That Suggests Initial Tumor Development and the Characteristics of cancer Stem Cells.
Matsumoto Y; Fukui T; Horitani S; Tanimura Y; Suzuki R; Tomiyama T; Honzawa Y; Tahara T; Okazaki K; Naganuma M
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511456
[TBL] [Abstract] [Full Text] [Related]
14. Activin A/ACVR2A axis inhibits epithelial-to-mesenchymal transition in colon cancer by activating smad2.
Zhang H; Ruan Q; Chen C; Yu H; Guan S; Hu D; Yang C; Lin R; Zhuo C
Mol Carcinog; 2023 Oct; 62(10):1585-1598. PubMed ID: 37378449
[TBL] [Abstract] [Full Text] [Related]
15. Mechanistic insights into the anti-tumor and anti-metastatic effects of Patrinia villosa aqueous extract in colon cancer via modulation of TGF-β R1-smad2/3-E-cadherin and FAK-RhoA-cofilin pathways.
Yang H; Yue GG; Yuen KK; Gao S; Leung PC; Wong CK; Lau CB
Phytomedicine; 2023 Aug; 117():154900. PubMed ID: 37269754
[TBL] [Abstract] [Full Text] [Related]
16. Nodal promotes colorectal cancer survival and metastasis through regulating SCD1-mediated ferroptosis resistance.
Wu T; Wan J; Qu X; Xia K; Wang F; Zhang Z; Yang M; Wu X; Gao R; Yuan X; Fang L; Chen C; Yin L
Cell Death Dis; 2023 Mar; 14(3):229. PubMed ID: 37002201
[TBL] [Abstract] [Full Text] [Related]
17. colorectal cancer inhibitory properties of polysaccharides and their molecular mechanisms: A review.
Ruan J; Zhang P; Zhang Q; Zhao S; Dang Z; Lu M; Li H; Zhang Y; Wang T
Int J Biol Macromol; 2023 May; 238():124165. PubMed ID: 36963537
[TBL] [Abstract] [Full Text] [Related]
18. Crosstalk between protein kinase C α and transforming growth factor β signaling mediated by Runx2 in intestinal epithelial cells.
Li X; Kaur N; Albahrani M; Karpf AR; Black AR; Black JD
J Biol Chem; 2023 Apr; 299(4):103017. PubMed ID: 36791912
[TBL] [Abstract] [Full Text] [Related]
19. Pelvic Recurrence After Curative Resection for Rectal Adenocarcinoma: Impact of Surgery on Survival.
Ferrari C; Cuniolo L; Mascherini M; Santoliquido M; DI Domenico S; DE Cian F
Anticancer Res; 2023 Feb; 43(2):765-771. PubMed ID: 36697092
[TBL] [Abstract] [Full Text] [Related]
20. Mutational analysis of microsatellite-stable gastrointestinal cancer with high tumour mutational burden: a retrospective cohort study.
Wang J; Xiu J; Farrell A; Baca Y; Arai H; Battaglin F; Kawanishi N; Soni S; Zhang W; Millstein J; Shields AF; Grothey A; Weinberg BA; Marshall JL; Lou E; Khushman M; Sohal DPS; Hall MJ; Liu T; Oberley M; Spetzler D; Korn WM; Shen L; Lenz HJ
Lancet Oncol; 2023 Feb; 24(2):151-161. PubMed ID: 36681091
[TBL] [Abstract] [Full Text] [Related]
[Next]
